These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a. Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046 [TBL] [Abstract][Full Text] [Related]
14. Needle size for vaccination procedures in children and adolescents. Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843 [TBL] [Abstract][Full Text] [Related]
16. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Engels EA; Falagas ME; Lau J; Bennish ML BMJ; 1998 Jan; 316(7125):110-6. PubMed ID: 9462316 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. Lin FY; Ho VA; Khiem HB; Trach DD; Bay PV; Thanh TC; Kossaczka Z; Bryla DA; Shiloach J; Robbins JB; Schneerson R; Szu SC N Engl J Med; 2001 Apr; 344(17):1263-9. PubMed ID: 11320385 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. Jin C; Gibani MM; Moore M; Juel HB; Jones E; Meiring J; Harris V; Gardner J; Nebykova A; Kerridge SA; Hill J; Thomaides-Brears H; Blohmke CJ; Yu LM; Angus B; Pollard AJ Lancet; 2017 Dec; 390(10111):2472-2480. PubMed ID: 28965718 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Black RE; Levine MM; Ferreccio C; Clements ML; Lanata C; Rooney J; Germanier R Vaccine; 1990 Feb; 8(1):81-4. PubMed ID: 2180234 [TBL] [Abstract][Full Text] [Related]